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What is already known about the topic?
•• The COVID-19 pandemic has directly and indirectly resulted in high mortality in many affected nations.
•• Internationally, the response has been focused on prevention and curative treatments, with little emphasis on pallia-
tive care needs of people dying during the COVID-19 pandemic.
•• We do not know how many of those dying with COVID-19 would have been in their last year of life in the absence of 
the pandemic, and this group may have distinct care needs.
What this paper adds?
•• The number of people dying in care homes increased by 220% during the first 10 weeks of the COVID-19 pandemic 
in England and Wales; many of these deaths were ‘additional deaths’, which is associated with the COVID-19 pan-
demic but not directly reported as a result of COVID-19.
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Abstract
Background: COVID-19 has directly and indirectly caused high mortality worldwide.
Aim: To explore patterns of mortality during the COVID-19 pandemic and implications for palliative care, service planning and research.
Design: Descriptive analysis and population-based modelling of routine data.
Participants and setting: All deaths registered in England and Wales between 7 March and 15 May 2020. We described the following 
mortality categories by age, gender and place of death: (1) baseline deaths (deaths that would typically occur in a given period); (2) 
COVID-19 deaths and (3) additional deaths not directly attributed to COVID-19. We estimated the proportion of people who died 
from COVID-19 who might have been in their last year of life in the absence of the pandemic using simple modelling with explicit 
assumptions.
Results: During the first 10 weeks of the pandemic, there were 101,614 baseline deaths, 41,105 COVID-19 deaths and 14,520 
additional deaths. Deaths in care homes increased by 220%, while home and hospital deaths increased by 77% and 90%, respectively. 
Hospice deaths fell by 20%. Additional deaths were among older people (86% aged ⩾ 75 years), and most occurred in care homes 
(56%) and at home (43%). We estimate that 22% (13%–31%) of COVID-19 deaths occurred among people who might have been in 
their last year of life in the absence of the pandemic.
Conclusion: The COVID-19 pandemic has led to a surge in palliative care needs. Health and social care systems must ensure availability 
of palliative care to support people with severe COVID-19, particularly in care homes.
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•• We estimate that just over one in five of all COVID-19 deaths occurred among people who might have been in their 
last year of life in the absence of the pandemic.
Implications for practice, theory or policy
•• Health and social care systems must ensure availability of palliative care to support people with severe COVID-19, 
particularly in care home settings.
•• The need for integrated models of palliative care in care home settings is key, and research to underpin these models 
is needed.
Introduction
Approaches to death and dying reveal much of the atti-
tude of society as a whole to the individuals who compose 
it (Cicely Saunders, 1984).1 The COVID-19 pandemic has 
led to an unprecedented surge in mortality around the 
world, with some countries such as United Kingdom, the 
United States and Italy particularly affected. In the United 
Kingdom and elsewhere, the government response has 
been focused on prevention and curative treatments. 
There has been very little emphasis internationally on 
care needs, including palliative care needs, for people 
dying during the COVID-19 pandemic.2
Clinical research and observation has found that people 
dying with COVID-19 are symptomatic, frequently experi-
encing breathlessness and agitation near the end of life.3 
Clinical uncertainty around the illness trajectories of those 
infected increases the complexity of clinical decision-mak-
ing and communication with patients and family.4 Deaths 
occurring during the COVID-19 pandemic are likely to be 
associated with poorer bereavement outcomes for family 
and friends and higher distress and support needs among 
frontline health and social care staff.5 There is an important 
role for palliative care, but the palliative care needs of the 
population have not been described.
Large-scale population-based studies exploring pat-
terns of mortality are important for anticipating numbers 
of people in need of care and for informing governments 
about the need to plan and reorganise services.6,7 Previous 
research suggests that up to 82% of people dying in a typi-
cal year have palliative care needs.8 However, the emer-
gence of COVID-19 has changed patterns of mortality. We 
currently lack an understanding of the palliative care 
needs for people dying during the COVID-19 pandemic at 
a population level.
In England and Wales, official mortality data from the 
Office for National Statistics (ONS) reveal that during the 
first 10 weeks of the pandemic (7 March to 15 May 2020), 
there were over 41,000 COVID-19 deaths, most occurring in 
hospitals (65%), with 28% in care homes and few elsewhere 
(7%).9 The ONS estimated that there were also over 14,000 
‘additional’ deaths, which were deaths over and above the 
number of deaths expected based on the 5-year average 
and which were not certified as caused by COVID-19.9 Most 
people dying with COVID-19 are older with underlying 
health conditions. The extent to which people dying with 
COVID-19 may have been in their last year of life in the 
absence of the COVID-19 pandemic has stimulated consid-
erable debate.10 Estimating this could help inform resource 
allocation and service planning, since the goals of care for 
those with a pre-existing advanced progressive or terminal 
illness may differ from those with no serious health con-
cerns prior to a COVID-19 infection.
This study aims to explore patterns of mortality during 
the first 10 weeks of the COVID-19 pandemic in England and 
Wales (7 March to 15 May 2020) to understand implications 
for palliative care, service planning and research. The objec-
tives are (1) to explore trends in place of death; (2) to explore 
the age and gender distribution of baseline deaths, COVID-
19 deaths and additional deaths; (3) to estimate the propor-
tion of people who died from COVID-19 who would have 
been in their last year of life, and differences by age; and (4) 
to use this information to discuss implications for palliative 
care provision, service planning and research.
Methods
Design and setting
Descriptive analysis and population-based modelling using 
routinely collected mortality data for England and Wales.
Data
We used publicly available data from the ONS including 
the following:
•• Weekly counts of registered deaths in England and 
Wales by age group from 2015 to 2019.
•• Weekly provisional counts of registered deaths in 
England and Wales in the weeks corresponding to 
the COVID-19 pandemic, between 7 March (week 
11) and 15 May 2020 (week 20), according to the 
date of registration.9 The week number refers to 
the week within the calendar year, for example, 
week 1 is the first week of January, which allows for 
comparison between the same period in previous 
years. We included data from the week beginning 
March 7, as this was the first week that deaths 
from COVID-19 were registered in England and 
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Wales, until the latest available data (week 20). 
ONS death registration figures are published 
11 days after the week ends due to the processing 
of data.9 Available data include all deaths and 
COVID-19 deaths by age, gender and place of 
occurrence over this time period.
•• Principal population projections of the total popu-
lation of England and Wales by age for 2020 
(2018-based).11
Death registration data have been used in previous 
studies examining national trends in place of death.6 In 
response to the pandemic, the ONS has released weekly 
death registration data, including deaths involving COVID-
19 and place of occurrence for all deaths. Guidance for 
professionals completing death certificates states that 
COVID-19 should be included as a contributing or underly-
ing cause of death, when this is suspected even in the 
absence of laboratory confirmation.12
Analysis
We first defined the following mortality categories: base-
line deaths, COVID-19 deaths and additional deaths, as 
detailed in Box 1.
Box 1. Definitions of mortality categories.
Terms Definition
Baseline deaths Deaths that would be expected to occur in a typical year without a pandemic. For this 
analysis we used the average number of deaths that occurred in the same period over the 
past 5 years.
COVID-19 deaths
(a)  COVID-19 deaths among 
annual baseline deaths
Deaths officially registered as with or from COVID-19. This category includes a subgroup:
(a)  People who died from COVID-19 who might have been in their last year of life in the 
absence of the pandemic.
Additional deaths Deaths in excess of baseline deaths that are not accounted for by deaths certified as being 
as a direct result of COVID-19. This group might include deaths due to COVID-19 but not 
recorded as such, or deaths indirectly related to the pandemic, for example, through 
avoidance of hospital care.
The numbers of people in each mortality category 
were calculated for England and Wales between 7 March 
(week 11) and 15 May 2020 (week 20) as follows:
1. Baseline deaths. We estimated the baseline deaths 
according to the average deaths in the 10-week period of 
interest (weeks 11 to 20) over the years 2015 to 2019, by 
age and gender.
2. COVID-19 deaths. Data on COVID-19 deaths were 
obtained from the ONS weekly registered deaths, which 
include deaths by age, gender and place of occurrence.9 
The ONS produces figures for deaths involving COVID-19 
based on any mention of COVID-19 on the death certifi-
cate, including when the physician suspects COVID-19 
based on symptoms but where no test was available.9 
These figures include deaths outside of hospital.
a) People who died from COVID-19 who might have 
been in their last year of life in the absence of the pan-
demic. First, we derived an estimate of the proportion of 
the population infected in each age group by re-arranging 
the following equation:
COVID-19 deaths = total population x proportion 
infected x infection fatality ratio.
The information we used in this equation included the 
number of registered COVID-19 deaths reported by ONS;9 
the total population from the ONS principal projections11 
and infection fatality ratios by 10-year age groupings 
obtained from the work by Ferguson et al.13,14 (supple-
mentary Table 1).
Second, we hypothesised that someone who is in their 
last year of life will have an increased risk of dying from 
COVID-19 compared to someone in the same age group 
who is not in their last year of life. To account for this, we 
applied a risk of dying multiplier to this group based on 
evidence of increased risk of death among people with 
serious conditions (supplementary Table 2). We applied a 
range of multipliers, with our primary estimate based on 
the median risk of death across different conditions.15 
Therefore, the number of people who die with COVID-19 
who would be expected to die within a year was calcu-
lated using the following equation:
COVID-19 deaths among those in their last year of 
life = baseline deaths x proportion infected x infection 
fatality ratio x risk of dying multiplier
3. Additional deaths. We calculated additional deaths by 
subtracting the estimated baseline deaths and COVID-19 
deaths from all registered deaths on a per week basis over 
the 10-week period of interest (weeks 11–20). This was 
calculated for each age and gender group separately to 
identify additional deaths within different demographic 
categories. Where this resulted in a negative value, the 
estimated baseline figure was reduced by this amount 
and the value for additional deaths was zero.1
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Age, gender and place of death. To understand the 
age and gender distribution of the COVID-19 and addi-
tional deaths, we grouped data into four age groups (<45, 
45–64, 65–74 and ⩾ 85 years) and compared them with 
baseline deaths over the period of interest (weeks 11–20). 
We described trends in place of occurrence of deaths using 
the ONS defined categories of ‘hospital’ (acute and com-
munity, not psychiatric), ‘care home’ (nursing and residen-
tial), ‘home’, ‘hospice’ and combined ‘other communal’ and 
‘elsewhere’. To estimate additional deaths by place of death 
over the period, we used place of death data for week 11 to 
estimate baseline place of death, as weekly place of death 
information was unavailable for previous years.
Patient and public involvement
We sought the views and experiences of members of our 
patient and public network regarding their concerns 
around COVID-19 pandemic. These consultations 
informed the focus and design of this study. Patient and 
public involvement (PPI) representatives provided feed-
back on the article.
Ethics
This study uses routinely collected anonymised and pub-
licly available data. No ethical approvals were necessary.
Results
Between 7 March and 15 May 2020 (weeks 11–20) in 
England and Wales, there were 157,239 deaths registered, 
of which 41,105 were from COVID-19. We estimate that this 
included 101,614 baseline deaths (as estimated by average 
weekly deaths over the same period during 2015–2019) and 
14,520 additional deaths (Figure 1). The lower number of 
deaths observed in week 19 is likely due to a public holiday 
in that week which delayed the registration of deaths.9
Place of death during the pandemic
Where people die in England and Wales has changed 
(Figure 2). Taking all deaths together, weekly hospital 
deaths increased by 90% from week 11 (n = 4975) to a 
peak in week 16 (n = 9434). We observe a 77% increase in 
home deaths between weeks 11 (n = 2725) and 17 
(n = 4834), while care home deaths increased by 220% 
during the same period (week 11 n = 2471 and week 17 
n = 7911). In week 18, care homes temporarily became 
the most common place to die. Hospice deaths fell by 20% 
between week 11 (n = 553) and week 19 (n = 441), repre-
senting 3% of deaths during the 10-week period.
Most COVID-19 deaths occurred in hospitals (65%) and 
care homes (28%), with few occurring at home and hos-
pice (5% and 1%, respectively). The location of the 
additional deaths has not been described. Comparing 
place of death for additional deaths occurring in weeks 
12–20 with week 11, we found the majority of additional 
deaths occurred in care homes (56%) and at home (43%) 
(Figure 3). During weeks 12–20, there were fewer addi-
tional deaths in hospitals and hospices compared to week 
11, indicating that there were fewer non-COVID-19 deaths 
in these settings than usual.
Mortality categories by age and gender
We found the age distribution of COVID-19 deaths to be 
overall older compared to baseline deaths, with 74% of 
COVID-19 deaths aged ⩾ 75 years compared to 68% of 
baseline deaths (Figure 4). Additional deaths are older 
Figure 1. All registered deaths during the COVID-19 pandemic 
between 7 March and 15 May 2020 (weeks 11–20) in England 
and Wales.
Figure 2. All registered deaths during the COVID-19 pandemic 
between 7 March and 15 May 2020 (weeks 11–20) in England 
and Wales by place of occurrence.
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still, with 83% aged ⩾ 75 years and 56% aged ⩾ 85 years. 
A greater proportion of COVID-19 deaths are male (56%), 
compared to 49% of baseline deaths and 50% of addi-
tional deaths.
People who died from COVID-19 who might 
have been in their last year of life in the 
absence of the pandemic
Among the people who are registered as dying with 
COVID-19, we have estimated a group who would be in 
their last year of life in the absence of the pandemic. 
Using our primary (and lower and upper) estimates for 
the risk of dying multiplier, we found that 22% (13%–31%) 
of people who died with COVID-19 over the period of 
interest were likely to be in their last year of life (Table 1 
and supplementary Figure 1). This increases with age, 
such that by ≥ 80 years, 33% (19%–47%) of people who 
die with COVID are likely in their last year of life in the 
absence of the pandemic.
Discussion
Main findings
Using routine data and modelling scenarios to understand 
mortality patterns during the COVID-19 pandemic, we 
highlight that care homes temporarily became the most 
common place to die in England and Wales, and that hos-
pital and home deaths increased by over 50%, while 
deaths in hospices fell by 20%. We show that people in 
the additional deaths category are proportionately more 
likely to be older, and to die in care homes and at home, 
than those who are certified as dying with COVID-19. 
Finally, we estimate for the first time that just over one in 
five COVID-19 deaths occur among people who might be 
in their last year of life in the absence of the pandemic, 
and that this increases to a third of those aged over 
85 years.
Implications for palliative care
Deaths in hospitals and care homes and at home increased 
during the first weeks of the COVID-19 pandemic. Rapid 
adaptation of models of palliative care is needed at the 
first sign of subsequent waves of the COVID-19 pandemic 
or future pandemics to support the increased number of 
people dying in these settings. Guidance on remote con-
sultations in primary care16 and on managing distressing 
symptoms in the community17 is available to help support 
care for people with suspected COVID-19, but challenges 
remain in terms of workforce and equipment. A pilot 
study of palliative care delivered in care homes via tel-
econference supported the feasibility of this approach 
where required.18 Specialist palliative care provision in 
care homes is currently variable,19–21 and guidance to sup-
port palliative care for people with COVID-19 in nursing 
homes has been found to be lacking and limited in focus.22 
In contrast, deaths in hospices fell during the time period. 
A similar phenomenon was found during the 2003 SARS 
pandemic and highlighted the need for seamless continu-
ity of care between settings.23 Systems that enable hos-
pice resources to rapidly shift from inpatient to community 
settings are likely to be important in future pandemic 
peaks.24
Little has been described about the characteristics of 
the additional deaths that have occurred during the 
COVID-19 pandemic. The aetiology of these deaths is not 
known, in particular whether they are undiagnosed COVID-
19 deaths or deaths associated with the pandemic without 
being a result of the disease (e.g. due to avoidance of 
Figure 3. Difference in the number of additional deaths (not 
attributed to COVID-19) in weeks 12–20 compared to week 11 
in 2020, by place of occurrence.
Figure 4. Age and gender distribution of baseline deaths, 
COVID-19 deaths and additional deaths between 7 March and 
15 May 2020 (weeks 11–20) in England and Wales.
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urgent healthcare).25 There is emerging evidence that 
older people with COVID-19 may present with non-specific 
and atypical symptoms such as delirium or low-grade 
fever.26 We found that the additional deaths group com-
prises predominantly older people in care homes, suggest-
ing that these may be undiagnosed COVID-19 deaths. 
Irrespective of aetiology, this group are likely to have sig-
nificant palliative care needs. The characteristics of the 
additional deaths population is likely to change as the pan-
demic progresses, and deferred harm from missed routine 
check-ups or screening becomes more likely.27
At a population level, we estimate that 22% of COVID-
19 deaths occur among people who might have been in 
their last year of life in the absence of the pandemic, and 
that among those aged > 85 years, 33% might be in their 
last year of life. For those with advanced conditions living 
at home and in care homes, guidelines recommend that 
general practitioners (GPs), community healthcare staff 
and community geriatricians urgently review advance 
care plans with patients and their families and discuss 
their care preferences in the case of contracting COVID-
19.17,28 These discussions are challenging, particularly 
when conducted over the telephone. Specialist palliative 
care services may play a role in offering advice and sup-
port for conducting difficult conversations in difficult 
situations.
While the focus of this article is COVID-19, it should be 
noted that baseline deaths outnumber COVID-19 and 
additional deaths. Previous modelling has shown that 
around 69%–82% of the baseline group are likely to have 
palliative care needs.8 COVID-19 will impact this group, for 
example, through fewer face-to-face contacts and poten-
tially less availability of specialist palliative care support, 
as services are suddenly stretched beyond their usual 
bounds. Informal caregivers are likely to play an important 
role in caring for those in home settings and may need 
additional support.29
Across all mortality categories, there is the need for 
bereavement support as a result of higher prevalence of 
complicated grief.30 There will be the typical grief associ-
ated with death and dying, but on a much larger scale. In 
addition, there will also be novel grief processes, linked to 
social isolation and distancing, self-blame around infec-
tion and not being able to attend funerals.31 Palliative care 
specialists with particular expertise in bereavement sup-
port have a role in supporting families in coping with 
bereavement and supporting colleagues to deliver this 
care alongside other relevant organisations.
Internationally, the COVID-19 pandemic has affected 
countries at different times and to varying degrees. The 
United Kingdom has experienced particularly high mortal-
ity during the COVID-19 pandemic.32 A common feature 
across nations affected by COVID-19 is the high propor-
tion of COVID-19 deaths among care home residents, for 
example, 34% in South Korea and 51% in France.33 All 
countries severely affected by COVID-19 will have a surge 
in need for palliative care, though country-level factors, 
such as socio-demographic characteristics, will influence 
the magnitude of this. National guidance on providing 
palliative care during pandemics, taking into account the 
structure of the health and social care system and level of 
integration of palliative care, is essential.34
Strengths and limitations
This is the first article to estimate and characterise popu-
lation-level patterns of mortality during the COVID-19 
pandemic in relation to palliative care. We have produced 
simple models with explicit assumptions to raise ques-
tions and stimulate discussion. We calculated additional 
Table 1. People who died from COVID-19 over the 10-week period from 7 March to 15 May 2020 who might have been in their last 
year of life in the absence of the pandemic.
Age Total 
population 
of England 
and Wales11
Baseline 
deaths over 
12 months 
(based on 
the 5-year 
average)
Total 
COVID-19 
deaths up 
to 15 May
Infection 
fatality ratio 
(based on 
the work by 
Ferguson et al 
2020)13
Estimated 
proportion 
infected with 
COVID-19 over 
the period
COVID-19 deaths among annual baseline 
deaths n (% of all COVID-19 deaths)
Multiplier of 
3.5 – primary 
estimate
Multiplier 
of 2 – lower 
estimate
Multiplier 
of 5 – upper 
estimate
0–9 7,142,647 3305 3 0.00% 2.1% 0 (0%) 0 (0%) 0 (0%)
10–19 6,908,476 2823 10 0.01% 2.4% 0 (0%) 0 (0%) 0 (0%)
20–29 7,654,985 4955 64 0.03% 2.8% 0 (0%) 0 (0%) 0 (0%)
30–39 7,973,235 4955 181 0.08% 2.8% 0 (0%) 0 (0%) 1(0%)
40–49 7,495,052 18,176 591 0.15% 4.3% 5 (1%) 3 (0%) 7 (1%)
50–59 8,080,681 31,396 1953 0.6% 4.0% 27 (1%) 15 (1%) 38 (2%)
60–69 6,371,654 59,543 4150 2.2% 3.0% 136 (3%) 78 (2%) 194 (5%)
70–79 5,149,885 119,014 9431 5.1% 3.6% 763 (8%) 436 (5%) 1090 (12%)
80 + 3,052,619 286,883 24,722 9.3% 8.7% 8132 (33%) 4647 (19%) 11,617 (47%)
Total 59,829,234 531,050 41,105 – – 9062 (22%) 5179 (13%) 12,946 (31%)
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deaths for each age and gender group separately to 
improve precision. However, this study has limitations. 
We have been limited by the available official data, includ-
ing the lack of historical data on place of death by week in 
England and Wales. Death registration figures can be 
affected by external factors such as public holidays, delays 
in processing or delays due to investigations by the coro-
ner. Therefore, the death figures included in this analysis 
may underestimate the true number of deaths over this 
period. We have used data for England and Wales, and 
patterns are likely to vary by country and region, particu-
larly with respect to care home deaths. The infection 
fatality ratio and risk of dying multipliers for those in their 
last year of life were based on the latest available data, 
and this might change over the course of the pandemic. 
Most of the underlying evidence for the multiplier is 
based on hospital studies; those dying with COVID-19 in 
care homes and at home are underrepresented.15
This study focused on mortality only. Other aspects of 
palliative care are important to be considered, for exam-
ple, symptom control, support with difficult conversa-
tions, advance care planning, and complex clinical 
decision-making.35 There are also longer-term needs 
among those surviving COVID-19, such as rehabilitation 
and palliative care, which are likely to be significant and 
important for service planning but were not modelled 
here. We have produced population-based models that 
are useful for strategic health service planning but are not 
directly applicable to clinical decision-making at an indi-
vidual level. For example, while we have estimated the 
number of people dying from COVID-19 who might have 
been in their last year of life in the absence of the pan-
demic at the population level, we acknowledge the chal-
lenges of prognostication at the individual level.36 Our 
estimates used the currently available data on the risk of 
death from COVID-19 across different conditions, and this 
multiplier should be revised as more data become 
available.
Implications for policy, data and future 
research
A population-level understanding of the palliative care 
needs of people with severe COVID-19 is essential to 
guide efficient health service planning, but has been miss-
ing from political rhetoric around the world, much of 
which has been focused on intensive care capacity. 
Greater support for care homes through closer collabora-
tion with primary care, specialist palliative care services 
and community geriatricians is needed for now and for 
future pandemics.37 Investment in palliative care training 
and education for social care staff so that they have the 
skills, competence and confidence to provide care to 
those approaching the end of life. Given the steep rise in 
deaths that have occurred in challenging circumstances, 
ensuring provision of bereavement support should be a 
priority.
COVID-19 is now the focus of much research, but very 
few studies are focused on palliative and end of life 
care.38,39 Data and research are urgently required to 
answer the following questions:
What are the best integrated models of palliative care 
in care homes that can be adapted for use during the 
COVID-19 pandemic?
What is the impact of COVID-19 on the hospice sector 
and how might hospice services best use their availa-
ble resources?
What is the impact of COVID-19 on complex grief, and 
what resources are needed to support those experi-
encing this?
What is the impact of COVID-19 on carers supporting 
people with palliative care needs in community 
settings?
Conclusion
Our study has highlighted the high level of need for pallia-
tive care during the COVID-19 pandemic. Healthcare sys-
tems responding to COVID-19 must consider the need for 
palliative care surge capacity, including the workforce and 
equipment, to enable people to be cared for appropri-
ately in all settings. The need for integrated models of pal-
liative care in care home settings is imperative. The rapid 
changes to practice during the pandemic provide impor-
tant opportunities for research, evaluation and learning, 
and it is essential that new models are underpinned by 
evidence.
Acknowledgements
We are grateful for the critical review from Janice Tausig, 
Richard Meade, Scott Murray and Helen Findlay.
Contributors
All authors conceived the idea for the study. A.E.B., A.M.F. and 
J.L. conducted the analyses. A.E.B. and K.E.S. wrote the first 
draft of the manuscript. All authors critically revised the manu-
script for intellectual content and approved the final version of 
the submitted manuscript. The corresponding author attests 
that all listed authors meet authorship criteria and that no one 
meeting the criteria have been omitted.
Data sharing
All data are publicly available
Declaration of conflicting interests
The author(s) declared the following potential conflicts of inter-
est with respect to the research, authorship, and/or publication 
8 Palliative Medicine 00(0)
of this article: All authors have completed the ICMJE uniform 
disclosure form at www.icmje.org/coi_disclosure.pdf and 
declare: no support from any organisation for the submitted 
work; no financial relationships with any organisations that 
might have an interest in the submitted work in the previous 3 
years; no other relationships or activities that could appear to 
have influenced the submitted work.
Funding
The author(s) disclosed receipt of the following financial support 
for the research, authorship, and/or publication of this article: 
This research was funded by The Dunhill Medical Trust and 
Cicely Saunders International. KES is funded by a National Insti-
tute of Health Research (NIHR) Clinician Scientist Fellowship (CS-
2015-15-005), IJH is an NIHR Senior Investigator Emeritus. IJH is 
supported by the NIHR Applied Research Collaboration South 
London (NIHR ARC South London) at King’s College Hospital NHS 
Foundation Trust. IJH leads the Palliative and End of Life Care 
theme of the NIHR ARC South London, and co-leads the national 
theme. AMF is funded by Marie Curie. The views expressed are 
those of the authors and not necessarily those of the NHS, the 
NIHR, the Department of Health and Social Care or the funding 
charities.
ORCID iDs
Anna E Bone  https://orcid.org/0000-0002-8800-9581
Anne M Finucane  https://orcid.org/0000-0002-3056-059X
Javiera Leniz  https://orcid.org/0000-0002-9315-4871
Irene J Higginson  https://orcid.org/0000-0002-3687-1313
Katherine E Sleeman  https://orcid.org/0000-0002-9777- 
4373
Supplemental material
Supplemental material for this article is available online.
References
 1. Saunders CM. Cicely Saunders: selected writings 1958-
2004. Oxford; New York: Oxford University Press, 2006.
 2. World Health Organisation. Coronavirus disease (COVID-
19) Pandemic, 2020, https://www.who.int/emergencies/
diseases/novel-coronavirus-2019
 3. Lovell N, Maddocks M, Etkind SN, et al. Characteristics, 
symptom management and outcomes of 101 patients 
with COVID-19 referred for hospital palliative care. J Pain 
Symptom Manage 2020; 60: E77–E81.
 4. Curtis JR, Kross EK and Stapleton RD. The importance of 
addressing advance care planning and decisions about 
do-not-resuscitate orders during novel coronavirus 2019 
(COVID-19). JAMA 2020; 323: 1771–1772.
 5. Selman LE, Chao D, Sowden R, et al. Bereavement support 
on the frontline of COVID-19: recommendations for hospi-
tal clinicians. J Pain Symptom Manage. Epub ahead of print 
3 May 2020. DOI: 10.1016/j.jpainsymman.2020.04.024.
 6. Bone AE, Gomes B, Etkind SN, et al. What is the impact 
of population ageing on the future provision of end-of-
life care? Population-based projections of place of death. 
Palliat Med 2018; 32(2): 329–336.
 7. Etkind SN, Bone AE, Gomes B, et al. How many people will 
need palliative care in 2040? Past trends, future projections 
and implications for services. BMC Med 2017; 15: 102.
 8. Murtagh FE, Bausewein C, Verne J, et al. How many peo-
ple need palliative care? A study developing and compar-
ing methods for population-based estimates. Palliat Med 
2014; 28(1): 49–58.
 9. Office for National Statistics. Deaths registered weekly in 
England and Wales, provisional. https://www.ons.gov.uk/
peoplepopulationandcommunity/birthsdeathsandmar-
riages/deaths/datasets/weeklyprovisionalfiguresondeath-
sregisteredinenglandandwales (2020, accessed 26 May 
2020).
 10. Spiegelhalter D. How much ‘normal’ risk does Covid rep-
resent?. https://medium.com/wintoncentre/how-much-
normal-risk-does-covid-represent-4539118e1196 (2020)
 11. Office for National Statistics. Principal projection – England 
and Wales population in age groups, https://www.ons.gov.
uk/peoplepopulationandcommunity/populationandmigra-
tion/populationprojections/datasets/tablea23principal-
projectionenglandandwalespopulationinagegroups (2019, 
accessed 12 May 2020).
 12. Office for National Statistics. Guidance for doctors complet-
ing medical certificates of cause of death in England and 
Wales for use during the emergency period only, https://
assets.publishing.service.gov.uk/government/uploads/
system/uploads/attachment_data/file/877302/guidance-
for-doctors-completing-medical-certificates-of-cause-of-
death-covid-19.pdf (2020, accessed 18 June 2020).
 13. Ferguson N, Laydon D, Nedjati-Gilani G, et al. Impact of 
non-pharmaceutical interventions (NPIs) to reduce COVID-
19 mortality and healthcare demand. Imperial College 
London, London, 2020.
 14. Centre for Evidence-Based Medicine. Global Covid-19 Case 
Fatality Rates, 2020, https://www.cebm.net/covid-19/
global-covid-19-case-fatality-rates
 15. Parohan M, Yaghoubi S, Seraji A, et al. Risk factors for mor-
tality in patients with Coronavirus disease 2019 (COVID-19) 
infection: a systematic review and meta-analysis of obser-
vational studies. Aging Male 2020; 8: 1–9.
 16. Greenhalgh T, Koh GCH and Car J. Covid-19: a remote 
assessment in primary care. BMJ 2020; 368: m1182.
 17. National Institute for Health Care Excellence. COVID-19 
rapid guideline: managing symptoms (including at the end 
of life) in the community, https://www.nice.org.uk/guid-
ance/ng163 (2020, accessed 8 May 2020).
 18. Perri GA, Abdel-Malek N, Bandali A, et al. Early integration 
of palliative care in a long-term care home: a telemedicine 
feasibility pilot study. Palliat Support Care 2020; 18; 1–8.
 19. Froggatt K and Payne S. A survey of end-of-life care in care 
homes: issues of definition and practice. Health Soc Care 
Community 2006; 14(4): 341–348.
 20. Ten Koppel M, Onwuteaka-Philipsen BD, Van den Block L, 
et al. Palliative care provision in long-term care facilities 
differs across Europe: results of a cross-sectional study in 
six European countries (PACE). Palliat Med 2019; 33(9): 
1176–1188.
 21. Collingridge Moore D, Payne S, Van den Block L, et al. 
Strategies for the implementation of palliative care edu-
cation and organizational interventions in long-term care 
Bone et al. 9
facilities: a scoping review. Palliat Med 2020; 34(5): 558–
570.
 22. Gilissen J, Pivodic L, Unroe KT, et al. International COVID-
19 palliative care guidance for nursing homes leaves key 
themes unaddressed. J Pain Symptom Manage. Epub 
ahead of print 11 May 2020. DOI: 10.1016/j.jpainsym-
man.2020.04.151.
 23. Chen TJ, Lin MH, Chou LF, et al. Hospice utilization during the 
SARS outbreak in Taiwan. BMC Health Serv Res 2006; 6: 94.
 24. Etkind SN, Bone AE, Lovell N, et al. The role and response 
of palliative care and hospice services in epidemics and 
pandemics: a rapid review to inform practice during the 
COVID-19 pandemic. J Pain Symptom Manage 2020; 60(1): 
e31–e40.
 25. Appleby J. What is happening to non-covid deaths? BMJ 
2020; 369: m1607.
 26. Tay HS and Harwood R. Atypical presentation of COVID-19 
in a frail older person. Age Ageing 2020; 49: 523–524.
 27. Sud A, Jones ME, Broggio J, et al. Collateral damage: 
the impact on cancer outcomes of the COVID-19 pan-
demic. Medrxiv. Epub ahead of print 28 April 2020. DOI: 
10.1101/2020.04.21.20073833.
 28. British Geriatrics Society. COVID-19: managing the COVID-
19 pandemic in care homes for older people, https://
www.bgs.org.uk/resources/covid-19-managing-the-covid-
19-pandemic-in-care-homes (2020, accessed 8 May 2020).
 29. Bowers B, Pollock K and Barclay S. Administration of end-
of-life drugs by family caregivers during covid-19 pandemic. 
BMJ 2020; 369: m1615.
 30. Kentish-Barnes N, Chaize M, Seegers V, et al. Complicated 
grief after death of a relative in the intensive care unit. Eur 
Respir J 2015; 45(5): 1341–1352.
 31. Wallace CL, Wladkowski SP, Gibson A, et al. Grief during 
the COVID-19 pandemic: considerations for palliative care 
providers. J Pain Symptom Manage 2020; 60(1): e70–e76.
 32. Roser M. Coronavirus pandemic – country comparisons, 
https://ourworldindata.org/coronavirus-country-compari-
sons (2020, accessed 18 June 2020).
 33. Comas-Herrera AZJ, Litwin C, Hsu AT, et al. Mortality associ-
ated with COVID-19 outbreaks in care homes: early inter-
national evidence. International Long Term Care Policy 
Network, 2020, https://ltccovid.org/2020/04/12/mortal-
ity-associated-with-covid-19-outbreaks-in-care-homes-
early-international-evidence/
 34. Connor SRBM. Global Atlas of Palliative Care at the End of 
Life, http://www.thewhpca.org/resources/global-atlas-on-
end-of-life-care (2014, accessed 14 November 2016).
 35. Bowman BA, Esch AE, Back AL, et al. Crisis symptom man-
agement and patient communication protocols are impor-
tant tools for all clinicians responding to COVID-19. J Pain 
Symptom Manage. Epub ahead of print 7 April 2020. 
DOI:10.1016/j.jpainsymman.2020.03.028
 36. Chu C, White N and Stone P. Prognostication in palliative 
care. Clin Med 2019; 19: 306–310.
 37. Gordon AL, Goodman C, Achterberg W, et al. Commentary: 
COVID in care homes – challenges and dilemmas in health-
care delivery. Age Ageing 2020; 2020: afaa113.
 38. National Institute for Health Research. Urgent Public Health 
COVID-19 Studies, https://www.nihr.ac.uk/covid-studies/ 
(2020, accessed 4 May 2020).
 39. UK Research Innovation. COVID-19 research and innovation 
supported by UKRI, 2020, https://www.ukri.org/research/
coronavirus/covid-19-research-and-innovation-supported-
by-ukri/
